Búsqueda | Portal de Búsqueda de la BVS España

1.

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.

Moore, Kathleen N; Angelergues, Antoine; Konecny, Gottfried E; García, Yolanda; Banerjee, Susana; Lorusso, Domenica; Lee, Jung-Yun; Moroney, John W; Colombo, Nicoletta; Roszak, Andrzej; Tromp, Jacqueline; Myers, Tashanna; Lee, Jeong-Won; Beiner, Mario; Cosgrove, Casey M; Cibula, David; Martin, Lainie P; Sabatier, Renaud; Buscema, Joseph; Estévez-García, Purificación; Coffman, Lan; Nicum, Shibani; Duska, Linda R; Pignata, Sandro; Gálvez, Fernando; Wang, Yuemei; Method, Michael; Berkenblit, Anna; Bello Roufai, Diana; Van Gorp, Toon.

N Engl J Med; 389(23): 2162-2174, 2023 Dec 07.

Artículo en Inglés | MEDLINE | ID: mdl-38055253

2.

Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.

Nicum, Shibani; McGregor, Naomi; Austin, Rachel; Collins, Linda; Dutton, Susan; McNeish, Iain; Glasspool, Rosalind; Hall, Marcia; Roux, Rene; Michael, Agnieszka; Clamp, Andrew; Jayson, Gordon; Kristeleit, Rebecca; Banerjee, Susana; Mansouri, Anita.

Br J Cancer; 130(6): 941-950, 2024 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-38245661

3.

A systematic review of ethnic minority participation in randomised controlled trials of systemic therapies for gynecological cancers.

Steventon, Luke; Nicum, Shibani; Man, Kenneth; Chaichana, Ubonphan; Wei, Li; Chambers, Pinkie.

Gynecol Oncol; 184: 178-189, 2024 Feb 07.

Artículo en Inglés | MEDLINE | ID: mdl-38330832

4.

Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.

Morgan, Robert D; Clamp, Andrew R; Barnes, Bethany M; Timms, Kirsten; Schlecht, Helene; Yarram-Smith, Laura; Wallis, Yvonne; Valganon-Petrizan, Mikel; MacMahon, Suzanne; White, Rhian; Morgan, Sian; McKenna, Sarah; Hudson, Emma; Tookman, Laura; George, Angela; Manchanda, Ranjit; Sundar, Sudha S; Nicum, Shibani; Brenton, James D; Kristeleit, Rebecca S; Banerjee, Susana; McNeish, Iain A; Ledermann, Jonathan A; Taylor, Stephen S; Evans, D Gareth R; Jayson, Gordon C.

Int J Gynecol Cancer; 33(8): 1253-1259, 2023 08 07.

Artículo en Inglés | MEDLINE | ID: mdl-37072323

5.

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.

Coleman, Robert L; Fleming, Gini F; Brady, Mark F; Swisher, Elizabeth M; Steffensen, Karina D; Friedlander, Michael; Okamoto, Aikou; Moore, Kathleen N; Efrat Ben-Baruch, Noa; Werner, Theresa L; Cloven, Noelle G; Oaknin, Ana; DiSilvestro, Paul A; Morgan, Mark A; Nam, Joo-Hyun; Leath, Charles A; Nicum, Shibani; Hagemann, Andrea R; Littell, Ramey D; Cella, David; Baron-Hay, Sally; Garcia-Donas, Jesus; Mizuno, Mika; Bell-McGuinn, Katherine; Sullivan, Danielle M; Bach, Bruce A; Bhattacharya, Sudipta; Ratajczak, Christine K; Ansell, Peter J; Dinh, Minh H; Aghajanian, Carol; Bookman, Michael A.

N Engl J Med; 381(25): 2403-2415, 2019 12 19.

Artículo en Inglés | MEDLINE | ID: mdl-31562800

6.

c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial.

Morgan, Robert D; Ferreras, Cristina; Peset, Isabel; Avizienyte, Egle; Renehan, Andrew G; Edmondson, Richard J; Murphy, Alexander D; Nicum, Shibani; Van Brussel, Thomas; Clamp, Andrew R; Lambrechts, Diether; Zhou, Cong; Jayson, Gordon C.

BMC Med; 20(1): 59, 2022 02 11.

Artículo en Inglés | MEDLINE | ID: mdl-35144591

7.

British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic.

Taylor, Alexandra; Sundar, Sudha S; Bowen, Rebecca; Clayton, Rick; Coleridge, Sarah; Fotopoulou, Christina; Ghaem-Maghami, Sadaf; Ledermann, Jonathan; Manchanda, Ranjit; Maxwell, Hilary; Michael, Agnieszka; Miles, Tracie; Nicum, Shibani; Nordin, Andrew; Ramsay, Bruce; Rundle, Stuart; Williams, Sarah; Wood, Nicholas J; Yiannakis, Dennis; Morrison, Jo.

Int J Gynecol Cancer; 32(1): 9-14, 2022 01.

Artículo en Inglés | MEDLINE | ID: mdl-34795019

8.

ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.

Elyashiv, Osnat; Ledermann, Jonathan; Parmar, Gita; Farrelly, Laura; Counsell, Nicholas; Feeney, Amanda; El-Khouly, Fatima; Macdonald, Ian; Neto, Andreia; Arthur-Darkwa, Esther; Burnett, Eva; Jayson, Gordon C; Mileshkin, Linda; Gourley, Charlie; Nicum, Shibani.

Int J Gynecol Cancer; 31(1): 134-138, 2021 01.

Artículo en Inglés | MEDLINE | ID: mdl-33097567

9.

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.

Sundar, Sudha; Manchanda, Ranjit; Gourley, Charlie; George, Angela; Wallace, Andrew; Balega, Janos; Williams, Sarah; Wallis, Yvonne; Edmondson, Richard; Nicum, Shibani; Frost, Jonathan; Attygalle, Ayoma; Fotopoulou, Christina; Bowen, Rebecca; Bell, Dani; Gajjar, Ketankumar; Ramsay, Bruce; Wood, Nicholas J; Ghaem-Maghami, Sadaf; Miles, Tracie; Ganesan, Raji.

Int J Gynecol Cancer; 31(2): 272-278, 2021 02.

Artículo en Inglés | MEDLINE | ID: mdl-33468564

10.

Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours.

Roberts, Corran; Strauss, Victoria Y; Kopijasz, Sylwia; Gourley, Charlie; Hall, Marcia; Montes, Ana; Abraham, Jacinta; Clamp, Andrew; Kennedy, Richard; Banerjee, Susana; Folkes, Lisa K; Stratford, Michael; Nicum, Shibani.

Br J Cancer; 122(4): 483-490, 2020 02.

Artículo en Inglés | MEDLINE | ID: mdl-31813938

11.

Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer.

Liu, Joyce; Nicum, Shibani; Reichardt, Peter; Croitoru, Kenneth; Illek, Beate; Schmidinger, Manuela; Rogers, Catherine; Whalen, Christin; Jayson, Gordon C.

Gynecol Oncol; 150(1): 173-179, 2018 07.

Artículo en Inglés | MEDLINE | ID: mdl-29627080

12.

A source of hope for platinum-resistant ovarian cancer?

Blagden, Sarah P; Nicum, Shibani.

Lancet; 397(10271): 254-256, 2021 01 23.

Artículo en Inglés | MEDLINE | ID: mdl-33485431

13.

A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol.

Nicum, Shibani; Roberts, Corran; Boyle, Lucy; Kopijasz, Sylwia; Gourley, Charlie; Hall, Marcia; Montes, Ana; Poole, Christopher; Collins, Linda; Schuh, Anna; Dutton, Susan J.

BMC Cancer; 14: 983, 2014 Dec 19.

Artículo en Inglés | MEDLINE | ID: mdl-25526776

14.

Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK.

Oxley, Samuel; Kalra, Ashwin; Sideris, Michail; Itzkowitz, Nicole; Evans, Olivia; Atakpa, Emma Christine; Brentnall, Adam R; Dworschak, Nina; Gaba, Faiza; Gabe, Rhian; Sundar, Sudha; Wood, Nick; Nicum, Shibani; Taylor, Alexandra; Dobbs, Stephen; McCluggage, W Glenn; Nordin, Andy; Legood, Rosa; Kehoe, Sean; Ghaem-Maghami, Sadaf; Manchanda, Ranjit.

Cancers (Basel); 15(4)2023 Feb 16.

Artículo en Inglés | MEDLINE | ID: mdl-36831615

15.

British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer.

Sundar, Sudha; Nordin, Andy; Morrison, Jo; Wood, Nick; Ghaem-Maghami, Sadaf; Nieto, Jo; Phillips, Andrew; Butler, John; Burton, Kevin; Gornall, Rob; Dobbs, Stephen; Glasspool, Rosalind; Peevor, Richard; Ledermann, Jonathan; McNeish, Iain; Ratnavelu, Nithya; Duncan, Tim; Frost, Jonathan; Lim, Kenneth; Michael, Agnieszka; Brockbank, Elly; Gajjar, Ketankumar; Taylor, Alexandra; Bowen, Rebecca; Andreou, Adrian; Ganesan, Raji; Nicum, Shibani; Edmondson, Richard; Clayton, Richard; Balega, Janos; Rolland, Phil; Maxwell, Hilary; Fotopoulou, Christina.

Cancers (Basel); 15(2)2023 Jan 04.

Artículo en Inglés | MEDLINE | ID: mdl-36672287

16.

PARPs: All for One and One for All? Enhancing Diversity in Clinical Trials.

Nicum, Shibani; Blagden, Sarah P.

Clin Cancer Res; 28(11): 2201-2203, 2022 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-35357469

17.

Epidermal growth factor receptor blockers for the treatment of ovarian cancer.

Haldar, Krishnayan; Gaitskell, Kezia; Bryant, Andrew; Nicum, Shibani; Kehoe, Sean; Morrison, Jo.

Cochrane Database Syst Rev; (10): CD007927, 2011 Oct 05.

Artículo en Inglés | MEDLINE | ID: mdl-21975775

18.

Angiogenesis inhibitors for the treatment of ovarian cancer.

Gaitskell, Kezia; Martinek, Igor; Bryant, Andrew; Kehoe, Sean; Nicum, Shibani; Morrison, Jo.

Cochrane Database Syst Rev; (9): CD007930, 2011 Sep 07.

Artículo en Inglés | MEDLINE | ID: mdl-21901715

19.

Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol.

Mansouri, Anita; McGregor, Naomi; Dunn, Rachel; Dobbie, Sam; Holmes, Jane; Collins, Linda; Nicum, Shibani.

BMJ Open; 11(1): e041463, 2021 01 15.

Artículo en Inglés | MEDLINE | ID: mdl-33452192

20.

A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer.

Kazmi, Farasat; Nicum, Shibani; Roux, Rene L; Spiers, Laura; Gnanaranjan, Chat; Sukumaran, Ajithkumar; Gabra, Hani; Ghazaly, Essam; McCracken, Nigel W; Harrison, David J; Blagden, Sarah P.

Clin Cancer Res; 27(11): 3028-3038, 2021 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-33741651

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: